reference/20637136

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20637136

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	816
issn	0028-4793 1533-4406
issueIdentifier	9
pageRange	808-816
publicationName	The New England journal of medicine
startingPage	808
bibliographicCitation	Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL; Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med. 2003 Feb 27;348(9):808–16. doi: 10.1056/nejmoa020681. PMID: 12606735.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b4ba21e91e730ebb7382e7429855843 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50c47eb8c33e5e58e1241bfdff5ae0a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64f9c138fcea5a42f93e8c7a63302bc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68b8ee9e7ece219beb8e7b739121c72e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca0b3d463e123bf6801959174831f48f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9bb46d95248b0db77f5ada057421927 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e3f5ef46158974d07327d3ee4d72e2a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c47e45a023b3ace2078e9aa6dbe71064 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a6826ec10818835dbf7945929e00459 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c20b31d235f77d4b0e6553eea7edc8e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_865480eccee19cd598e2c850bec365d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5999b8cc238115410be4ab468ce9d931
date	2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12606735 https://doi.org/10.1056/nejmoa020681
isPartOf	https://portal.issn.org/resource/ISSN/0028-4793 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985 https://portal.issn.org/resource/ISSN/1533-4406
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
discusses	http://id.nlm.nih.gov/mesh/M0000347 http://id.nlm.nih.gov/mesh/M0278180 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0571031 http://id.nlm.nih.gov/mesh/M0000620 http://id.nlm.nih.gov/mesh/M0010216 http://id.nlm.nih.gov/mesh/M0006695
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D063065 http://id.nlm.nih.gov/mesh/D000998Q000627 http://id.nlm.nih.gov/mesh/D000225Q000031 http://id.nlm.nih.gov/mesh/D000225Q000627 http://id.nlm.nih.gov/mesh/D019694Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000410Q000097 http://id.nlm.nih.gov/mesh/D008099Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019694Q000821 http://id.nlm.nih.gov/mesh/D006515Q000302 http://id.nlm.nih.gov/mesh/D019694Q000473 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019694Q000097 http://id.nlm.nih.gov/mesh/D004279Q000097 http://id.nlm.nih.gov/mesh/D006515Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000998Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006513Q000097 http://id.nlm.nih.gov/mesh/D000225Q000009 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631

Total number of triples: 71.